Nephros, Inc. (NEPH)
3.34
+0.11
(+3.41%)
USD |
NASDAQ |
May 08, 10:57
Nephros Research and Development Expense (Annual) : 1.339M for Dec. 31, 2025
Research and Development Expense (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Annual) Benchmarks
| Cerus Corp. | 65.72M |
| Xtant Medical Holdings, Inc. | 2.102M |
| Abbott Laboratories | 2.889B |
| Accuray, Inc. | 47.94M |
| Plus Therapeutics, Inc. | 8.379M |